{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T13:47:59Z","timestamp":1793022479043,"version":"4.5.0"},"reference-count":28,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T00:00:00Z","timestamp":1755043200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Aging Neurosci."],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>The gut-brain axis is recognized as a critical pathway through which gut microbiota influences neurological health. However, the complex interplay between gut microbiota composition, blood\u2013brain barrier (BBB) integrity, and cognitive function in elderly individuals with coronary heart disease (CHD) experiencing mild cognitive impairment (MCI) remains insufficiently elucidated. This study aimed to investigate these relationships in a cohort of 40 elderlies with CHD, comparing those with MCI to those with normal cognition (NC), focusing on microbial diversity, specific taxa alterations, BBB permeability, and their correlations with cognitive performance.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This preplanned secondary analysis utilized data from two prospective cohort studies, enrolling elderlies with CHD (\u226560\u202fyears). Participants were categorized into NC (<jats:italic>n<\/jats:italic>\u202f=\u202f20) and MCI (<jats:italic>n<\/jats:italic>\u202f=\u202f20) groups based on standardized neuropsychological assessments. Fecal samples underwent 16S rRNA gene sequencing (V3-V4 region) to evaluate gut microbiota diversity and composition. BBB permeability was quantified using dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI), specifically measuring the volume transfer constant (Ktrans) in the hippocampus.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Compared to the NC group, MCI patients exhibited significantly reduced gut microbial <jats:italic>\u03b1<\/jats:italic>-diversity (Chao1 index: <jats:italic>p<\/jats:italic>\u202f=\u202f0.002; Shannon index: <jats:italic>p<\/jats:italic>\u202f=\u202f0.009) and distinct <jats:italic>\u03b2<\/jats:italic>-diversity profiles (Bray\u2013Curtis dissimilarity, PERMANOVA, <jats:italic>p<\/jats:italic>\u202f=\u202f0.003). LEfSe analysis identified depletion of key short-chain fatty acid (SCFA)-producing taxa in the MCI group, including at the family level (Ruminococcaceae, <jats:italic>p<\/jats:italic>\u202f=\u202f0.016; Rikenellaceae, <jats:italic>p<\/jats:italic>\u202f=\u202f0.042; and Barnesiellaceae, <jats:italic>p<\/jats:italic>\u202f=\u202f0.038) and genus level (Faecalibacterium, <jats:italic>p<\/jats:italic>\u202f=\u202f0.003 and Oscillospira, <jats:italic>p<\/jats:italic>\u202f=\u202f0.002). Hippocampal BBB permeability (Ktrans) was significantly elevated in MCI patients (6.04\u202f\u00b1\u202f3.02 vs. 3.90\u202f\u00b1\u202f1.03\u202f\u00d7\u202f10<jats:sup>\u22123<\/jats:sup> min<jats:sup>\u22121<\/jats:sup>, <jats:italic>p<\/jats:italic>\u202f=\u202f0.006) and inversely correlated with the relative abundance of Faecalibacterium (Spearman\u2019s r\u202f=\u202f\u22120.466, <jats:italic>p<\/jats:italic>\u202f=\u202f0.002) and Oscillospira (Spearman\u2019s r\u202f=\u202f\u22120.322, <jats:italic>p<\/jats:italic>\u202f=\u202f0.043). Conversely, these genera showed positive correlations with Montreal Cognitive Assessment-Basic (MoCA-B) scores (Faecalibacterium: r\u202f=\u202f0.596, <jats:italic>p<\/jats:italic>\u202f&amp;lt;\u202f0.001; Oscillospira: r\u202f=\u202f0.369, <jats:italic>p<\/jats:italic>\u202f=\u202f0.019).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Elderlies with CHD and MCI demonstrate significant gut dysbiosis, characterized by reduced microbial diversity and depletion of SCFA-producing taxa, notably butyrate producers. These microbial alterations are correlated with increased BBB permeability in the hippocampus and diminished cognitive function. These findings highlight the potential role of the gut-brain axis in the pathogenesis of cognitive decline in this vulnerable population and suggest that targeting gut microbiota could be a therapeutic avenue.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fnagi.2025.1640761","type":"journal-article","created":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T05:32:50Z","timestamp":1755063170000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Gut dysbiosis is associated with increased blood\u2013brain barrier permeability and cognitive impairment in elderlies with coronary heart disease"],"prefix":"10.3389","volume":"17","author":[{"given":"Lichao","family":"Di","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiying","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeju","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liwei","family":"Chi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lining","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,8,13]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.jalz.2011.03.008","article-title":"The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease","volume":"7","author":"Albert","year":"2011","journal-title":"Alzheimers Dement."},{"key":"ref2","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1038\/s41587-019-0209-9","article-title":"Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2","volume":"37","author":"Bolyen","year":"2019","journal-title":"Nat. Biotechnol."},{"key":"ref3","doi-asserted-by":"publisher","first-page":"112497","DOI":"10.1016\/j.exger.2024.112497","article-title":"Influence of human gut microbiome on the healthy and the neurodegenerative aging","volume":"194","author":"Borrego-Ruiz","year":"2024","journal-title":"Exp. Gerontol."},{"key":"ref4","doi-asserted-by":"publisher","first-page":"263ra158","DOI":"10.1126\/scitranslmed.3009759","article-title":"The gut microbiota influences blood-brain barrier permeability in mice","volume":"6","author":"Braniste","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"ref5","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.1097\/CM9.0000000000002206","article-title":"Gut microbiota and microbiota-derived metabolites in cardiovascular diseases","volume":"136","author":"Chen","year":"2023","journal-title":"Chin. Med. J."},{"key":"ref6","doi-asserted-by":"publisher","first-page":"3568","DOI":"10.1111\/ene.15961","article-title":"Gut microbiome characteristics in subjective cognitive decline, mild cognitive impairment and Alzheimer's disease: a systematic review and meta-analysis","volume":"30","author":"Chen","year":"2023","journal-title":"Eur. J. Neurol."},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1152\/physrev.00018.2018","article-title":"The microbiota-gut-brain Axis","volume":"99","author":"Cryan","year":"2019","journal-title":"Physiol. Rev."},{"key":"ref8","doi-asserted-by":"publisher","first-page":"e0184244","DOI":"10.1371\/journal.pone.0184244","article-title":"Coronary heart disease and risk for cognitive impairment or dementia: systematic review and meta-analysis","volume":"12","author":"Deckers","year":"2017","journal-title":"PLoS One"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1136\/gutjnl-2020-321747","article-title":"Gut microbiome stability and resilience: elucidating the response to perturbations in order to modulate gut health","volume":"70","author":"Fassarella","year":"2021","journal-title":"Gut"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1410246","DOI":"10.3389\/fmed.2024.1410246","article-title":"Mild cognitive impairment and microbiota: what is known and future perspectives","volume":"11","author":"Gallo","year":"2024","journal-title":"Front. Med."},{"key":"ref11","doi-asserted-by":"publisher","first-page":"e008831","DOI":"10.1136\/jitc-2024-008831","article-title":"Inhibition of the NF-\u03baB\/HIF-1\u03b1 signaling pathway in colorectal cancer by tyrosol: a gut microbiota-derived metabolite","volume":"12","author":"Guo","year":"2024","journal-title":"J. Immunother. Cancer"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"4399","DOI":"10.1128\/AEM.67.10.4399-4406.2001","article-title":"Counting the uncountable: statistical approaches to estimating microbial diversity","volume":"67","author":"Hughes","year":"2001","journal-title":"Appl. Environ. Microbiol."},{"key":"ref13","doi-asserted-by":"publisher","first-page":"e661","DOI":"10.1016\/S2468-2667(20)30185-7","article-title":"Prevalence, risk factors, and management of dementia and mild cognitive impairment in adults aged 60 years or older in China: a cross-sectional study","volume":"5","author":"Jia","year":"2020","journal-title":"Lancet Public Health"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"5102","DOI":"10.3390\/nu14235102","article-title":"Extra-virgin olive oil enhances the blood-brain barrier function in mild cognitive impairment: a randomized controlled trial","volume":"14","author":"Kaddoumi","year":"2022","journal-title":"Nutrients"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"4499","DOI":"10.1007\/s12035-024-04545-2","article-title":"Association between the gut microbiota and alzheimer\u2019s disease: an update on signaling pathways and translational therapeutics","volume":"62","author":"Kulkarni","year":"2025","journal-title":"Mol. Neurobiol."},{"key":"ref16","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/s41392-024-01743-1","article-title":"Microbiota-gut-brain axis and its therapeutic applications in neurodegenerative diseases","volume":"9","author":"Loh","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref17","doi-asserted-by":"publisher","first-page":"140945","DOI":"10.1016\/j.ijbiomac.2025.140945","article-title":"Dynamic changes in the gut microbiota play a critical role in age-associated cognitive dysfunction via SCFAs and LPS synthesis metabolic pathways during brain aging","volume":"304","author":"Ma","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"ref18","doi-asserted-by":"publisher","first-page":"9742","DOI":"10.1038\/s41598-018-28048-y","article-title":"Butyrate produced by gut commensal bacteria activates TGF-beta1 expression through the transcription factor SP1 in human intestinal epithelial cells","volume":"8","author":"Martin-Gallausiaux","year":"2018","journal-title":"Sci. Rep."},{"key":"ref19","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41591-018-0297-y","article-title":"Blood-brain barrier breakdown is an early biomarker of human cognitive dysfunction","volume":"25","author":"Nation","year":"2019","journal-title":"Nat. Med."},{"key":"ref20","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1080\/19490976.2019.1638722","article-title":"Gut microbes and metabolites as modulators of blood-brain barrier integrity and brain health","volume":"11","author":"Parker","year":"2020","journal-title":"Gut Microbes"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1212\/WNL.0000000000004826","article-title":"Practice guideline update summary: mild cognitive impairment [RETIRED]: report of the guideline development, dissemination, and implementation subcommittee of the American Academy of Neurology","volume":"90","author":"Petersen","year":"2018","journal-title":"Neurology"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1038\/s41598-024-84780-8","article-title":"Protection of Alzheimer's disease progression by a human-origin probiotics cocktail","volume":"15","author":"Prajapati","year":"2025","journal-title":"Sci. Rep."},{"key":"ref23","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3389\/fendo.2020.00025","article-title":"The role of short-chain fatty acids from gut microbiota in gut-brain communication","volume":"11","author":"Silva","year":"2020","journal-title":"Front. Endocrinol."},{"key":"ref24","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.jalz.2011.03.003","article-title":"Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease","volume":"7","author":"Sperling","year":"2011","journal-title":"Alzheimers Dement."},{"key":"ref25","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.neuint.2018.08.005","article-title":"Unhealthy gut, unhealthy brain: the role of the intestinal microbiota in neurodegenerative diseases","volume":"120","author":"Spielman","year":"2018","journal-title":"Neurochem. Int."},{"key":"ref26","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1161\/CIRCRESAHA.117.309715","article-title":"Gut microbiota in cardiovascular health and disease","volume":"120","author":"Tang","year":"2017","journal-title":"Circ. Res."},{"key":"ref27","doi-asserted-by":"publisher","first-page":"100398","DOI":"10.1016\/j.xcrm.2021.100398","article-title":"Identification of Faecalibacterium prausnitzii strains for gut microbiome-based intervention in Alzheimer's-type dementia","volume":"2","author":"Ueda","year":"2021","journal-title":"Cell Rep. Med."},{"key":"ref28","doi-asserted-by":"publisher","first-page":"4474","DOI":"10.1093\/brain\/awac236","article-title":"Activation of Wnt\/\u03b2-catenin pathway mitigates blood-brain barrier dysfunction in Alzheimer's disease","volume":"145","author":"Wang","year":"2022","journal-title":"Brain"}],"container-title":["Frontiers in Aging Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnagi.2025.1640761\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T05:32:51Z","timestamp":1755063171000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnagi.2025.1640761\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,13]]},"references-count":28,"alternative-id":["10.3389\/fnagi.2025.1640761"],"URL":"https:\/\/doi.org\/10.3389\/fnagi.2025.1640761","relation":{},"ISSN":["1663-4365"],"issn-type":[{"value":"1663-4365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,13]]},"article-number":"1640761"}}